• Case Report
  • |
  • Open Access
  • |
  • ISSN: 2637-4501

Adderall Delaying Colorectal Cancer Diagnosis

    • Andriy Barchuk
      • Department of Internal Medicine, Kent Hospital, Warwick, USA.
  • Corresponding Author(s): Andriy Barchuk

  • Department of Internal Medicine, Kent Hospital, Warwick, USA.

  • andriy_barchuk@brown.edu

  • Barchuk A (2022).

  • This Article is distributed under the terms of Creative Commons Attribution 4.0 International License

Received : Mar 10, 2022
Accepted : Mar 29, 2022
Published Online : Mar 31, 2022
Journal : Annals of Gastroenterology and the Digestive System
Publisher : MedDocs Publishers LLC
Online edition : http://meddocsonline.org

Cite this article: Barchuk A. Adderall Delaying Colorectal Cancer Diagnosis. Ann Gastroenterol Dig Syst. 2022; 5(1): 1055.

Introduction

      Colon and rectal cancer is the third most common cancer accounting for 1.93 million new cases in the year 2020. It is the second most common cause of cancer deaths in recent years. Newest guidelines suggest screening for colorectal cancer starting at the age of 45 for average-risk individuals of 40 years old or 10 years prior to youngest affected first-degree relative under the age of 60 or two or more first-degree relatives at any age with colorectal cancer or advanced polyp. This case is an example of a health-literate patient who missed warning signs suggestive of colorectal cancer secondary to initiation of Adderall and likely missed diagnoses in a deceased first-degree family member.

Case presentation

      42 year old male patient who works as a paramedic and a firefighter with past medical history of hypertension, depression, ADHD, anemia, gallstone pancreatitis, Hodgkin’s lymphoma (in remission for 12 years), and status post gastric bypass 9 years ago came to the hospital for evaluation of right upper quadrant abdominal pain for the past 3 days not alleviated by ibuprofen. Patient denied nausea, vomiting, black/tarry or bright red blood in his stool. Patient endorsed good oral intake. He had no family history of colorectal cancer but mother passed away in her 40s from a bowel obstruction and subsequent perforation and sepsis of unknown etiology (no autopsy was performed). Patient has never had a colonoscopy in the past. He was started on Adderall a few months ago for ADHD and endorsed mildly decreased appetite during the day and a 20-30 pound weight loss since initiation of the medication, which the patient attributed to the initiation of medication. Patient had a 10-pack year smoking history, quit 14 years ago, and now intermittently smokes cigars. On admission, he was found to have hemoglobin of 11, abdominal CT showed exophytic mass in the transverse colon and a lesion in the right hepatic lobe. Patient underwent a colonoscopy that revealed a mass in the distal ascending colon (Figure 1 & 2). Biopsies were taken with cold forceps for histology, which were positive for adenocarcinoma. He subsequently underwent right colectomy with primary anastomosis. Patient was then started on a modified FOLFOX6 chemotherapy regimen.

Figure 1: Colonoscopy view of the mass at the hepatic flexure.

Figure 2: Colonoscopy view of the mass at the ascending colon.

Discussion

      Weight loss is always a red flag pointing practitioners towards the possibility of a malignancy. This patient's unfortunate coincidence of initiation of Adderall with likely weight loss from malignancy delayed his presentation. His mother's passing at a young age with no autopsy done at that time prevented the possibility of the patient initiating screening colonoscopies at an earlier age if a colorectal cancer was the source of the bowel obstruction. This combination of factors delayed the diagnosis of colorectal adenocarcinoma in a very health-literate patient.

MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.